Direct-acting Antiviral Drugs Market contains market size and forecasts of Direct-acting Antiviral Drugs in Global, including the following market information:
- Global Direct-acting Antiviral Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Direct-acting Antiviral Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- NS3/4A Protease Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Direct-acting Antiviral Drugs include AbbVie Inc., GSK, Boehringer Ingelheim, Merck, Novartis, Beximco Pharmaceuticals, Roche, Bristol-Myers Squibb Company and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Direct-acting Antiviral Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Direct-acting Antiviral Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Direct-acting Antiviral Drugs Market Segment Percentages, by Type, 2021 (%)
- NS3/4A Protease Inhibitors
- Nucleoside and Nucleotide NS5B Polymerase Inhibitors
- NS5A Inhibitors
- Non-Nucleoside NS5B Polymerase Inhibitors
Global Direct-acting Antiviral Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Direct-acting Antiviral Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Pharmacies
- Others
Global Direct-acting Antiviral Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Direct-acting Antiviral Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Direct-acting Antiviral Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Direct-acting Antiviral Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie Inc.
- GSK
- Boehringer Ingelheim
- Merck
- Novartis
- Beximco Pharmaceuticals
- Roche
- Bristol-Myers Squibb Company
- Gilead Sciences
- Janssen (Johnson & Johnson)
- Vertex Pharmaceuticals
- Natco Pharma
Industry Market Size
